baber/WOPTO huggingface dataset:
Patent NZ-549388-A (NZ)
Title: Equipment for transporting chips and chip carrier structure therefor
Inventor: CHARLIER GERRARD
IPC: G06K7/08
Filed: 2005-07-28
Abstract: Equipment for transporting chips with electronic circuit carrying coded information in a memory is disclosed. The equipment includes a movable structure carrying chips arranged in columns or stacks and at least one first docking station for the carrier structure in a place of storage. The docking station integrates all or part of at least one station of contactless radiofrequency reception type, adapted to read the coded information carried by the memory of the chips of at least one column or stack to determine or verify the content of at least one batch of chips present in the carrier structure. The carrier structure has a base adapted to receive at least one rack of chips, and a removable lid disposed on the base and adapted to enclose the rack or racks and the chips they contain. The read station comprises at least one wide-loop antenna individual loop integrated into a wall of the lid of the carrier structure. The carrier structure can alternatively comprises a base which is adapted to receive two stacks of chip racks disposed one on each side of a separating partition fastened to the base and provided with holding means. The read station can alternatively comprises at least one wide-loop antenna individual loop integrated into the separator partition of the carrier structure.
Patent NZ-550290-A (NZ)
Title: Methods and compositions for epilation
Inventor: TANERI JIM
Filed: 2006-10-03
Abstract: The present disclosure relates to methods and compositions useful for preparing a body surface for epilation. More specifically the disclosure relates to a composition that is adapted to leave a powder residue on a body surface prior to epilation. The powder residue is intended to cause body hair to be removed to 'stand up' through the action of static electricity making it easier to remove.
Patent NZ-551663-A (NZ)
Title: Indole derivatives as histamine receptor antagonists
Inventor: HERTEL CORNELIA
IPC: A61P3/04
Filed: 2005-06-13
Abstract: Disclosed are compounds of the general formula I wherein X is O or S, R4 is ûO-Het and R5 is hydrogen, or R4 is hydrogen or fluoro and R5 is ûO-Het and wherein the rest of the substituents are disclosed within the specification and pharmaceutically acceptable salts thereof. Also disclosed is the use of the above compounds for the preparation of medicaments for the treatment and/or prevention of diseases which are associated with the modulation of H3 receptors. Also disclosed is a process for the manufacture of the above compounds.
Patent NZ-553378-A (NZ)
Title: Thin pocket mattress, and method and device for its manufacturing
Inventor: LUNDEVALL ANDREAS
IPC: A47C27/06
Filed: 2005-09-08
Abstract: A spring mattress is described, comprising a plurality of strings interconnected side by side, each string comprising a continuous casing material with a plurality of pockets, said pockets being defined by at least one longitudinal connecting line extending parallel to the longitudinal direction of the string and a plurality of transverse connecting lines extending transversely to the longitudinal direction of the string, and coil springs arranged in the pockets of the string. For at least one of the springs, casing material portions arranged at the ends of the spring are moved towards each other, through the spring, and connected to each other. Moreover "the connecting lines are arranged at the side of the springs and, thus, between neighbouring springs. Preferably, the interconnected casing material portions are thus at the ends of the springs essentially free of other connections. Also a method and a device for manufacturing such a mattress are disclosed.
Patent NZ-561339-A (NZ)
Title: Enclosure system for underground utility connections
Inventor: BURKE EDWARD J
IPC: H02G3/18
Filed: 2006-03-09
Abstract: An underground utilities enclosure and distribution assembly comprising a grade level box 12 adapted for installation below ground and having an upper opening facing an interior region for containing a below-ground electrical utility cable, a removable split cover plate adapted for mounting to the opening in the grade level box 12 to close off the interior region thereof from the environment, the split cover plate comprising a pedestal mounting section 22 and a separate cover section 24, each section of the cover plate having a traction surface, and a pedestal housing 32, the pedestal mounting section 22 further comprising a base, a plug opening in the base for access to the interior region of the grade level box 12, and a plug that removably mounts in the plug opening for closing off the interior region of the grade level box 12 from the environment, the plug having a traction surface contiguous with the traction surface of the pedestal mounting section 22, the plug removable from the plug opening to provide access between the inside of the grade level box 12 and an interior region inside the pedestal housing 32, the plug further having a configuration that matches the configuration of the plug opening, the plug opening configuration adapted to match a configuration at a base of the pedestal housing 32 to facilitate mounting the pedestal housing 32 above the plug opening to position the pedestal housing 32 above-ground for use in receiving electrical connections to a utility cable contained in the grade level box 12 and brought above-ground level inside the pedestal housing 32.
Patent NZ-561377-A (NZ)
Title: Oral dosage forms of gemcitabine derivatives
Inventor: MYHREN FINN
IPC: A61K/
Filed: 2006-03-07
Abstract: Disclosed is the use of a gemcitabine derivative of formula I: wherein R1, R2 and R3 are independently selected from the list consisting of hydrogen, a C18- saturated acyl group, a C18- mono-unsaturated acyl group, a C20- saturated acyl group and a C20- mono-unsaturated acyl group, with the proviso that R1, R2 and R3 cannot all be hydrogen or a pharmaceutical acceptable salt thereof, for preparing an oral dosage form comprising from about 0.1 mg to 20 grams per day of a gemcitabine derivative of formula (I) or a pharmaceutical acceptable salt thereof, in treatment of cancer.
Patent NZ-568272-A (NZ)
Title: Anti-alpha2 integrin antibodies and their uses
Inventor: LAZARIDES ELIAS
IPC: A61P37/02
Filed: 2006-11-17
Abstract: Disclosed is an humanized anti-a2 integrin antibody comprising: (i) a heavy chain variable region comprising the amino acid sequence of (a) HCDR2 (VIWARGFTNYNSALMS, SEQ ID NO:2), (b) HCDR1 (GFSLTNYGIH, SEQ ID NO:1), HCDR2 (VIWARGFTNYNSALMS, SEQ ID NO:2) and HCDR3 (ANDGVYYAMDY, SEQ ID NO:3), or (c) SEQ ID NO:40; and (ii) a light chain variable region comprising the amino acid sequence of (a) an LCDR1 selected from SANSSVNYIH (SEQ ID NO:4) or SAQSSVNYIH (SEQ ID NO:112), (b) LCDR2 (DTSKLAS; SEQ ID NO:5) and (c) LCDR3 (QQWTTNPLT, SEQ ID NO:6). Also disclosed is an humanized anti-a2 integrin antibody, wherein the antibody binds an epitope of a2 integrin, the epitope comprising: (a) a Lys residue corresponding to position 192 of the a2 integrin amino acid sequence set forth in SEQ ID NO:8 or position 40 of the a2 integrin I domain amino acid sequence set forth in SEQ ID NO:11; (b) an Asn residue corresponding to position 225 of the a2 integrin amino acid sequence set forth in SEQ ID NO:8 or position 73 of the a2 integrin I domain amino acid sequence set forth in SEQ ID NO:11; (c) a Gln residue corresponding to position 241 of the a2 integrin amino acid sequence set forth in SEQ ID NO:8 or position 89 of the a2 integrin I domain amino acid sequence set forth in SEQ ID NO:11; (d) a Tyr residue corresponding to position 245 of the a2 integrin amino acid sequence set forth in SEQ ID NO:8 or position 93 of the a2 integrin I domain amino acid sequence set forth in SEQ ID NO:11; (e) an Arg residue corresponding to position 317 of the a2 integrin amino acid sequence set forth in SEQ ID NO:8 or position 165 of the a2 integrin I domain amino acid sequence set forth in SEQ ID NO:11; (f) an Asn residue corresponding to position 318 of the a2 integrin amino acid sequence set forth in SEQ ID NO:8 or position 166 of the a2 integrin I domain amino acid sequence set forth in SEQ ID NO:11; or (g) any combination of (a) to (f). Also disclosed is the use of the said anti-á2 integrin antibody for the manufacture of a medicament for the treatment of an a2b1 integrin associated disorder.
Patent NZ-568753-A (NZ)
Title: Two-sided non-stick release film with apertured intermediate release layer having release surface on both sides
Inventor: BARNETT BRAD L
IPC: A61F13/15
Filed: 2006-11-22
Abstract: Assemblies (100) for the adhesive attachment to the skin or mucosa of a host are disclosed. The assembly or transdermal patch includes an outer backing layer (112), a first layer of adhesive (110) on the inner surface of the outer backing layer (112), an inner backing layer (124), and an intermediate release liner (104) between the first layer of adhesive (110) and the inner backing layer (124). The intermediate release liner (104) includes a releasable surface on both its inner and outer surfaces.
Patent NZ-569635-A (NZ)
Title: Wall or fencing system of pre-cast concrete forms with enclosed space for non-structural purpose, and panels spanning forms and engaging with form formations
Inventor: LUCAS BRENDAN TRACY
IPC: E04B2/90
Filed: 2009-10-02
Abstract: A wall or fencing system has pre-cast concrete forms with wall(s) enclosing an interior volume and providing structure to the form with the interior volume configured to perform a non-structural auxiliary function. The forms have exterior formations, typically slots, so as to receive and support panel ends of panels spanning between the forms.
Patent NZ-573198-A (NZ)
Title: Multiple stage blower and enclosure therefor
Inventor: REED NICHOLAS JEROME
IPC: F04D17/12
Filed: 2004-06-10
Abstract: An enclosure for a blower used in the administration of positive pressure ventilation of a patient, the enclosure including: an enclosure base 710 defining a blower chamber for the blower: an enclosure lid 730 provided to sealingly engage the enclosure base; and a flow meter 740 provided upstream of the blower chamber.
Patent NZ-575192-A (NZ)
Title: N-phenyl-prenylamine derivatives for the treatment of cognitive, neurodegenerative or neuronal diseases or disorders
Inventor: MARTINEZ GIL ANA
IPC: C07C229/60
Filed: 2007-08-01
Abstract: Disclosed herein are N-phenyl-prenylamine derivatives of formula (I) wherein the substituents are as defined within the specification, compositions comprising said compounds, process for their preparation and the use of the compounds in the treatment and/or prophylaxis of a cognitive, neurodegenerative or neuronal disease or disorders such as: Alzheimer's Disease, Parkinson's Disease, multiple sclerosis, stroke, epilepsy, mood disorders, ischaemia, brain injury and chronic inflammatory diseases.
Patent NZ-576358-A (NZ)
Title: Method and apparatus for controlling a waterjet-driven marine vessel
Inventor: MORVILLO ROBERT A
IPC: B63H11/11
Filed: 2004-07-15
Abstract: A system for controlling a marine vessel having first and second waterjets comprising corresponding first and second steering nozzles and corresponding first and second reversing buckets, is disclosed. The system further includes a processor configured to receive a first vessel control signal and that is configured to provide at least one first actuator control signal and a first set of actuator control signals. The at least one first actuator control signal is to be coupled to and control the first and second steering nozzles, and the first set of actuator control signals are to be coupled to and control the first and second reversing buckets, The processor is configured to provide the first set of actuator control signals so that the first reversing bucket is positioned in a first discrete position and the second reversing bucket is positioned in a second discrete position, in response to receipt of the first vessel control signal that corresponds to a translational thrust command having a component in one of a port and a starboard direction, and to maintain the first reversing bucket in the first discrete position and the second reversing bucket in the second discrete position for all first vessel control signals that correspond to the translational thrust command having the component in the one of the port and the starboard direction. (62) Divided Out of 545018
Patent NZ-580310-A (NZ)
Title: Quinoline derivatives as crth2 receptor ligands
Inventor: RAY NICHOLAS CHARLES
IPC: C07D215/22
Filed: 2007-03-29
Abstract: Disclosed are the following compounds: [3-(4-cyanobenzyl)-4-difluoromethoxy-2-ethyl-8-fluoroquinolin-5-yloxy]acetic acid, [3-(4-bromobenzyl)-4-difluoromethoxy-2-ethyl-8-fluoroquinolin-5-yloxy]acetic acid, [4-ethyl-8-fluoro-3-(4-methanesulfonylbenzyl)-2-methylquinolin-5-yloxy]acetic acid, [2-ethyl-8-fluoro-3-(4-methanesulfonylbenzyl)-4-methylquinolin-5-10 yloxy]acetic acid, [4-difluoromethoxy-2-ethyl-8-fluoro-3-(4-methoxycarbonylaminobenzyl)quinolin-5- yloxy]acetic acid, [4-difluoromethoxy-2-ethyl-8-fluoro-3-(3-methanesulfonylbenzyl)quinolin-5- yloxy]acetic acid, (S)-2-[3-(4-chlorobenzyl)-4-difluoromethoxy-2-ethyl-8-fluoroquinolin-5-yloxy]propionic acid, { 4-difluoromethoxy-2-ethyl-8-fluoro-3-[4-(1-hydroxy-1-methylethyl)benzyl]quinolin-5- yloxy} acetic acid, [8-chloro-3-(4-cyanobenzyl)-4-difluoromethoxy-2-ethylquinolin-5-yloxy]acetic acid, 25 [8-chloro-3-(2-chloro-4-cyanobenzyl)-4-difluoromethoxy-2-ethylquinolin-5-yloxy]acetic acid, [8-chloro-3-(4-cyanobenzyl)-2-difluoromethoxy-4-methylquinolin-5-yloxy]acetic acid, [3-(4-cyanobenzyl)-2-difluoromethoxy-8-fluoro-4-methylquinolin-5-yloxy]acetic acid, and salts, N-oxides, hydrates and solvates thereof. Also disclosed is the use of the above compounds for treating asthma, chronic obstructive pulmonary disease, rhinitis, allergic airway syndrome, allergic rhinobronchitis, psoriasis, atopic and non-atopic dermatitis Crohn's disease, ulcerative colitis, or irritable bowel disease.
Patent NZ-588961-A (NZ)
Title: A wafer or cereal product comprising maltodextrin or a fructooligosaccharide
Inventor: ARRACHID ABDESSAMAD
IPC: A21D2/18
Filed: 2009-06-12
Abstract: Disclosed is a no- or low-sugar wafer or wafer batter that is moisture resistant or moisture tolerant, containing 0 to 15 percent by weight sweetener based on the weight of the wafer, or an expanded extruded cereal product comprising maltodextrins or fructooligosaccharides, wherein said maltodextrins or fructooligosaccharides have a monodisperse molecular distribution and wherein the distribution of maltodextrin or fructooligosaccharide molecules is such that: - The polydispersity index (PDI) is 18 or above; - 0 to 30 percent by weight of molecules have a degree of polymerisation of 5 or below; - Greater than 40 percent by weight of molecules have a degree of polymerisation from 6 to 300; and - The highest DP values are greater than 1000.
Patent NZ-592429-A (NZ)
Title: PHENANTHROINDOLIZIDINE DERIVATIVE AND NFkB INHIBITOR CONTAINING SAME AS ACTIVE INGREDIENT
Inventor: IKEDA TAKASHI
IPC: A61K31/437
Filed: 2009-10-23
Abstract: Disclosed herein are phenanthiroindolizidine derivatives of formula (I), wherein the substituents are as defined within the specification, processes for its preparation, compositions comprising said compounds and uses thereof. Said compounds are useful as Nuclear Factor-êB (NFêB) inhibitors and is therefore useful in the treatment of diseases associated with accelerated NFêB activity, such as cancer.
Patent NZ-597919-A (NZ)
Title: Biocidal composition for wood, method for wood treatment, and wood produced thereby
Inventor: NISSINEN TIMO
IPC: A01N37/02
Filed: 2009-07-14
Abstract: 597919 Disclosed herein is a method for treating wood in order to improve its properties of use and storage, and to thus obtained treated wood product wherein said treated wood product comprises formate at least 0.1 % by weight. In the method the wood to be treated is contacted with a treatment composition comprising monoester, diester or triester or a mixture thereof formed by a water soluble C1-C1O alcohol and formic acid as an equilibrium solution. In addition, the invention relates to specific treatment solution compositions which comprises of 1-99 % by weight glyceryl formate, free formic acid, glycerol and water, and a chelating agent which comprises phosphonic acid or a salt thereof, and a hydrophobicity rendering agent.
Patent NZ-599068-A (NZ)
Title: Drip irrigation system with filter membranes on inside of conduit corresponding to location of drip nozzles so as water flowing through conduit washes filter membrane of impurities, avoiding nozzle blockage
Inventor: ZHU JUN
IPC: B05B1/20
Filed: 2009-09-29
Abstract: A filtration irrigation method, filtration irrigation device and the manufacturing method thereof, said filtration irrigation device comprises a water carrying chamber (1), in which one or more porous filter membranes (2) are arranged. One or more flow restrictors (3) corresponding to each membrane (2) are set on the wall of the water carrying chamber (1). The total permeation capacity of the flow restrictors is less than that of said filter membranes. The present invention can avoid the blockage of the device effectively.
Patent NZ-599315-A (NZ)
Title: Antibody therapeutics with local activity in the digestive tract
Inventor: FOX BARBARA S
IPC: A61K39/395
Filed: 2010-10-15
Abstract: 599315 Disclosed is the use of a polyclonal, milk-derived, anti-TNF antibody in the manufacture of a medicament to treat inflammatory bowel disease wherein the peak level of anti-TNF antibody in the patient’s serum is less than about 1 microgram/ml after administration of the medicament.
Patent NZ-600540-A (NZ)
Title: Ethanol production in non-recombinant hosts
Inventor: KIM YOUNGNYUN
IPC: C12N1/20
Filed: 2007-04-26
Abstract: 572363 Discloses a method for producing ethanol from an oligosaccharide source comprising contacting the oligosaccharide with an isolated non-recombinant bacterium comprising a nucleic acid sequence of SEQ ID NO: 1 or 3 or a polypeptide encoded by SEQ ID NO: 2 or 4, wherein the bacterium is capable of producing ethanol as the primary fermentation product.
Patent NZ-618231-A (NZ)
Title: System for and method of generating a weld with selection of weld control algorithms according to set voltage magnitude
Inventor: PUTNAM GEOFFREY H
IPC: B23K9/10
Filed: 2012-05-25
Abstract: Disclosed is a system for generating a weld. The system comprises a power circuit for generating welding output power for a welding process; and a control circuit in communication with the power circuit and having a plurality of weld control algorithms. The control circuit configured to receive a selected welding process from a plurality of welding processes. The plurality of welding processes includes gas metal arc welding, flux core arc welding, shielded metal arc welding, and inert gas welding. The control circuit receives a selected value of a magnitude of an output voltage (310). The control circuit automatically selects a first weld control algorithm (330) from a plurality of weld control algorithms in the case that the selected value of the magnitude of the output voltage for the selected welding process, is in a first range of values and generate and provide power to the welding machine based on the first weld control algorithm. The control circuit automatically selects a second weld control algorithm (340) from the plurality of weld control algorithms in the case that the selected value of the magnitude of the output voltage is in a second range of values for the selected welding process, and generate and provide power to the welding machine based on the second algorithm.
Patent NZ-623027-A (NZ)
Title: Sterilized liquid protein supplement
Inventor: LAMB CATHERINE S
IPC: A23L33/00
Filed: 2012-10-12
Abstract: The disclosure relates to a sterilized liquid protein supplement comprising more than 10 grams of protein per 100 mL of supplement, wherein at least 35% by weight of the protein is hydrolysed casein having a degree of hydrolysis of at least 20% and wherein the sterilized liquid protein supplement has a pH of from about 5.0 to about 8.0. The disclosure also relates to the method of manufacturing the supplement and methods of fortifying breast milk and infant formula using the supplement.
Patent NZ-626486-A (NZ)
Title: Method for producing cooked and frozen pasta
Inventor: WATANABE TAKENORI
IPC: A23L7/113
Filed: 2012-12-21
Abstract: The disclosure relates to a method for producing cooked and frozen pastas, comprising the steps of boiling fresh pastas obtained by extruding dough into pasta noodles at a pressure of from 80 kgf/cm2 to 200 kgf/cm2, bringing the resulting boiled pasta into contact with a liquid comprising an oil or fat having a melting point of 10°C or less, and then freezing the pasta which has been brought into contact with the liquid.
Patent NZ-627274-A (NZ)
Title: Anesthetic compounds and related methods of use
Inventor: RAINES DOUGLAS E
IPC: A61K31/4164
Filed: 2013-01-11
Abstract: Disclosed herein are phenylethyl-imidazole-carboxylic acid derivatives according to formula (I), wherein the variables are as defined in the specification. Provided herein is also a pharmaceutical composition comprising a compound according to formula (I) and a pharmaceutically acceptable carrier, and a method for providing anesthesia in a subject by administering such a pharmaceutical composition. These compounds are useful as an anesthetic or sedative.
Patent NZ-701640-A (NZ)
Title: Mobile test system and methods for in situ characterization of stress and deflection dependent stiffness and bearing capacity of soils and geo-materials
Inventor: WHITE DAVID JOSHUA
IPC: G01N33/24
Filed: 2013-04-05
Abstract: An integrated mobile test system and methods for characterizing in situ stress or strain/deflection - dependent stiffness and bearing capacity enables the testing of engineering properties of natural, compacted, stabilized, and reinforced soils and geo-materials. The mobile test system and associated methods (1) prepare the ground for testing and (2) apply static or cyclic loading to one or more bearing plates of various geometries positioned at the ground surface or below the ground surface to determine both stress and deflection dependent stiffness relationships and the bearing capacity of the soil or geo-material. Optionally, the mobile test system and associated methods (3) apply ground confining stress conditions independent of the bearing plate loading.
Patent NZ-708450-A (NZ)
Title: Lock
Inventor: EDWARD NORTON SIEGLAAR
IPC: E05B63/08
Filed: 2014-05-28
Abstract: Disclosed is a lock comprising a lock housing, a lock bolt, a lock bolt lock and an actuator that moves the lock bolt between a locking and unlocking position by acting on a first lock bolt driver in one direction and a second lock bolt driver in the other. The drivers are mounted by said lock bolt to move with it between the locking and unlocking positions. The drivers are each displaceable or deflectable, against a bias, by the actuator relative to both the lock bolt and the actuator. The actuator is movable into a space between the drivers by displacing or deflecting one of them relative to both the lock bolt and the actuator. The displaceable or deflectable drivers significantly alleviate the risk of jamming thereby allowing less strict dimensional tolerances to be used in fabricating the actuator, the drivers and/or other components.